Thu. 22 Feb 2024, 7:24am ET
Benzinga
Earnings, News
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.88) by 35.23 percent. This is a 5.56 percent increase over losses of $(1.26) per share from the same period last year.